151 material Form 8-K filings that 136 companies we cover made with the SEC in February 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Expedia Group committed to restructuring actions on February 22, 2024, to recalibrate resources amid an organizational and technological transformation. The company expects a workforce reduction affecting about 1,500 employees, with notifications to some affected staff beginning February 26, 2024. Total pre-tax charges and cash costs of $80 million to $100 million are expected to be recorded in 2024, mostly for employee severance and compensation benefits.
About 1,500 employees expected to be affected by the workforce reduction
Total pre-tax charges and cash expenditures expected at $80 million to $100 million, all in 2024
Costs are predominantly employee severance and compensation benefits
Communication to a portion of affected employees began February 26, 2024
Dorman Products reported fourth-quarter 2023 net sales of $494.3 million, down 1% from a year earlier because the prior-year quarter included an extra week, while diluted EPS rose to $1.60 from $0.57. For full year 2023, net sales rose 11% to $1.93 billion, but adjusted diluted EPS fell 5% to $4.54, and the company issued 2024 guidance for diluted EPS of $4.71 to $5.01.
Q4 2023 net sales were $494.3 million, down 1% from $501.3 million; the company estimates the extra week in Q4 2022 contributed $19 million, and excluding it sales rose 3%.
Q4 2023 diluted EPS was $1.60 versus $0.57, and adjusted diluted EPS was $1.57 versus $1.01.
Full year 2023 diluted EPS was $4.10 versus $3.85, while adjusted diluted EPS was $4.54 versus $4.76.
2024 guidance calls for net sales growth of 3% to 5%, diluted EPS of $4.71 to $5.01, and adjusted diluted EPS of $5.40 to $5.70; the company also reorganized into three segments and will hold a conference call on February 27, 2024.
Erie Indemnity reported fourth-quarter 2023 net income of $110.9 million, or $2.12 per diluted share, up from $65.5 million, or $1.25, a year earlier. Full-year 2023 net income was $446.1 million, or $8.53 per diluted share, compared with $298.6 million, or $5.71, in 2022. The board also approved a quarterly Class A dividend of $1.275 per share, up from $1.190 a year earlier.
Q4 2023 total operating revenue was $817.7 million, up from $700.6 million in Q4 2022
Q4 2023 operating income rose 56.1% to $127.1 million, per the filing's highlights
Board approved Class A dividend of $1.275 per share, with a record date of April 9, 2024 and payable date of April 23, 2024
Results will be discussed in a pre-recorded webcast on February 27, 2024 at 10:00 a.m. ET
CarGurus reported fourth-quarter 2023 total revenue of $223.1 million, down 22% from a year earlier, and a GAAP consolidated net loss of $22.6 million, compared with net income of $23.2 million in the prior-year quarter. Marketplace revenue rose 10% to $182.3 million, and non-GAAP consolidated adjusted EBITDA rose 120% to $61.2 million, but the GAAP loss was driven in part by $55.5 million of stock-based compensation tied to CarOffer, LLC Units. The company also gave first-quarter 2024 revenue guidance of $201 million to $221 million.
Q4 2023 total revenue was $223.1 million, down 22%; full-year revenue was $914.2 million, down 45%.
Q4 GAAP consolidated net loss was $(22.6) million; full-year GAAP consolidated net income was $22.1 million, down 72%.
Q1 2024 guidance: total revenue of $201 million to $221 million, adjusted EBITDA of $41 million to $49 million, non-GAAP EPS of $0.24 to $0.29.
Chief People Officer Andrea Eldridge steps down effective April 5, 2024, with a $258,750 lump-sum severance payment.
Berkshire Hathaway reported fourth-quarter 2023 net earnings attributable to shareholders of $37.6 billion, up from $18.1 billion a year earlier, and operating earnings of $8.5 billion, up from $6.6 billion. Investment and derivative gains of $29.1 billion made up most of the net earnings increase, and the company says investment gains in any quarter are usually not indicative of business performance. For the full year, net earnings were $96.2 billion compared with a loss of $22.8 billion in 2022.
Q4 2023 net earnings of $37.6 billion versus $18.1 billion in Q4 2022, including investment and derivative gains of $29.1 billion
Q4 2023 operating earnings of $8.5 billion versus $6.6 billion; insurance-underwriting earnings rose to $848 million from $160 million
Full-year 2023 net earnings of $96.2 billion versus a $22.8 billion loss in 2022; full-year operating earnings of $37.4 billion versus $30.9 billion
Berkshire repurchased about $2.2 billion of its shares in Q4 2023 and about $9.2 billion for the full year
International Bancshares reported 2023 net income of $411.8 million, or $6.62 per diluted share, up from $300.2 million, or $4.78 per diluted share, in 2022. Fourth-quarter net income was $106.4 million, up 1.0% from $105.4 million a year earlier, while total deposits and total assets declined over the year.
Full-year 2023 net income was $411.8 million, up 37.2% from $300.2 million in 2022
Diluted earnings per share were $6.62 for 2023, compared with $4.78 in 2022, an increase of 38.5%
Fourth-quarter 2023 net income was $106.4 million, compared with $105.4 million for the same period in 2022
Deposits were $11.8 billion at December 31, 2023, down from $12.7 billion; total assets were $15.1 billion, down from $15.5 billion
PSEG reported full-year 2023 net income of $2.56 billion, or $5.13 per share, up from $1.03 billion, or $2.06 per share, in 2022. Non-GAAP operating earnings were $3.48 per share, close to the $3.47 reported for 2022, and fourth-quarter results declined from a year earlier. The company reaffirmed its 2024 non-GAAP operating earnings guidance of $3.60 to $3.70 per share.
Full-year 2023 operating revenues were $11.24 billion, compared with $9.80 billion in 2022.
Fourth-quarter 2023 net income was $546 million, or $1.10 per share, versus $788 million, or $1.58 per share, in the fourth quarter of 2022.
Full-year 2023 non-GAAP operating earnings were $3.48 per share; the company said this came in at the high end of its 2023 guidance range.
Management reaffirmed 2024 non-GAAP operating earnings guidance of $3.60 to $3.70 per share and set an indicative 2024 annual common dividend rate of $2.40 per share, up $0.12.
Krystal Biotech reported fourth-quarter and full-year 2023 results, with net product revenue of $42.1 million in the quarter and $50.7 million for the year from VYJUVEK, which was approved in May 2023. The company posted net income of $8.7 million for the quarter versus a $32.1 million loss a year earlier, and $10.9 million for the year, which includes a $100.0 million gain from selling a Priority Review Voucher. The company also gave 2024 non-GAAP R&D and SG&A expense guidance of $150.0 million to $175.0 million.
Q4 2023 net product revenue was $42.1 million, versus no product revenue in Q4 2022.
Q4 2023 net income was $8.7 million ($0.31 per basic share), compared with a loss of $32.1 million in Q4 2022.
Full-year 2023 net income was $10.9 million, including a $100.0 million gain from the sale of a Priority Review Voucher.
2024 non-GAAP combined R&D and SG&A expense guidance is $150.0 million to $175.0 million; cash and investments were $594.1 million at December 31, 2023.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.